Resverlogix is currently being covered by the following analysts:

Dr. Simos Simeonidis, Ph.D., Director and Senior Biotechnology Analyst with Rodman & Renshaw in New York, NY.

Dr. David Martin, Ph.D., MBA, Analyst, Biotechnology & Healthcare with Dundee Securities Corporation in Toronto, ON.

Claude Camiré, Biotech & Healthcare Analyst, Paradigm Capital in Toronto, ON.